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Background. The technique of one lung 
ventilation (OLV) is used with the pur-
pose of achieving isolation of the diseased 
lung being operated upon, using a double-
lumen endobronchial tube. Thoracic surgi-
cal procedures which are performed in the 
lateral decubitus position, nowadays could 
not be imagined without OLV. In spite of 
advantages regarding surgical exposure, 
OLV is associated with serious respiratory 
impairment. Hypoxemia is considered to 
be the most important challenge during 
OLV. The goal of this study was to establish 
the magnitude of intrapulmonary shunt, as 
well as the immensity of hypoxia during 
general anesthesia with OLV.
Materials and Methods. In this prospective 
interventional clinical study thirty patients 
were enrolled who underwent elective 
thoracic surgery with a prolonged period 
of OLV. The patients received balanced 
general anesthesia with fentanyl/propofol/
rocuronium. A double-lumen endobron-
chial tube was inserted in all patients, and 
mechanical ventilation with 50% oxygen in 
air was used during the entire study. Arte-
rial blood gases were recorded in a lateral 
decubitus position with two-lung ventila-
tion, at the beginning of OLV (OLV 0) 
and at 10 and 30 min. (OLV 10, OLV 30, 
respectively) after initiating OLV in all 
patients. Standard monitoring procedures 
were used. Arterial oxygenation (PaO2), 
arterial oxygen saturation (SaO2) and ve-
nous admixture percentage - intrapulmo-
nary shunt (Qs/Qt %) were measured, as 
well as mean arterial pressure and heart 
rate during the same time intervals. For 
the purpose of this study, the quantitative 
value of Qs/Qt% was mathematically cal-
culated using the blood gas analyser AVL 
Compact 3. A p value <0.05 was taken to 
be statistically significant.
Results. When OLV was instituted, arterial 
oxygenation decreased, whereas Qs/Qt% 
increased, about 10 min. after commence-
ment, with improvement of oxygenation 
approximately half an hour afterwards. A 
statistically relevant difference (p<0.05) 
occurred in PaO2, SaO2 and Qs/Qt at the 
different time points.
Conclusion. Hypoxia during OLV, with an 
increase in Qs/Qt, usually occurs after 10 
min. of its initiation. After 30 min, the val-
ues of the Qs/Qt ratio regularly return to 
normal levels.
Key words: one-lung ventilation, thoracic 
surgery, venous admixture, intrapulmonary 
shunt
INTRODUCTION
In order to achieve collapse of the affected 
lung during thoracic surgical procedures, a 
technique of ventilation of one lung (OLV) 
was introduced by inserting a double lu-
men endobronchial tube. This allows isola-
tion of the dependent lung from the affect-
ed, independent lung, which is on top, thus 
preventing contamination of the healthy 
lung. On the other hand, the collapse of 
the affected lung causes serious functional 
respiratory disorders that require special 
compensatory measures to avoid hypox-
emia. It should be emphasized that main-
taining optimum oxygenation is crucial for 
preventing cellular hypoxia. (1-3)
During OLV with the patient in the lateral 
decubitus position, there is a potential risk 
of significant intrapulmonary shunting of 
deoxygenated pulmonary arterial blood, 
which may result in hypoxemia. A conse-
quence of the increase in pulmonary vas-
cular resistance (PVR) in the independent 
(unventilated) lung, predominantly as a 
result of activated hypoxic pulmonary va-
soconstriction (HPV), is a redistribution 
of blood flow in the ventilated depend-
ent lung. Thus, an excessive drop of par-
tial pressure of oxygen in arterial blood 
(PaO2) is prevented. (4-8)
Intrapulmonary shunt is the main cause of 
hypoxemia in OLV, although alveoli with 
low ventilation/perfusion coupling (Va/
Qt) in the dependent lung contribute to 
that. In addition, the blood that goes into 
the upper lung cannot take oxygen, so 
it keeps the mixed venous composition, 
which is poorly oxygenated. It is mixed 
with oxygenated blood in the left atrium 
of the heart, creating the so-called venous 
admixture and reducing PaO2. Venous ad-
mixture and intrapulmonary shunt (Qs/
Qt) are often used as synonyms. Venous 
mixture increases from values of approxi-
mately 10-15% in ventilation of the two 
lungs (TLV) to 30-40% in OLV. In most 
patients, PaO2 can have values in the range 
of 9-16 kPa using a fraction of inspired 
oxygen (FiO2) 50-100%.
Hypoxic pulmonary vasoconstriction 
(HPV) is a compensatory mechanism by 
which the pulmonary blood flow is divert-
ed away from hypoxic/collapsed areas of 
the lung. This should improve oxygenation 
during OLV. Volatile anesthetics directly 
depress HPV, but they also amplify it by 
decreasing cardiac output (CO). Therefore, 
there is usually no change in the response 
to HPV when using volatile anesthetics 
during thoracotomy and OLV. Intravenous 
anesthetics, such as propofol, do not inhib-
it HPV and should improve arterial oxy-
genation in OLV. There is some evidence 
in support of this. (9-16)
The purpose of the study was to determine 
the magnitude of the intrapulmonary 
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shunt and hypoxia during general anesthe-
sia and OLV in thoracic surgery.
MATERIAL AND METHODS 
This study was part of a larger prospective 
clinical trial designed to investigate the in-
fluence of thoracic epidural anesthesia on 
intrapulmonary shunt during OLV in tho-
racic surgery. It was conducted at the Uni-
versity clinic of anesthesia, reanimation 
and intensive therapy and the University 
clinic of thoracic-vascular surgery, Uni-
versity Clinical Centre in Skopje, with the 
collaboration from our colleagues from the 
Department of anesthesiology and periop-
erative intensive therapy from the Univer-
sity Medical Centre in Ljubljana. The study 
was performed in accordance with the 
Declaration of Helsinki and after receiv-
ing approval from the Ethics Committee of 
the Medical Faculty in Skopje. Each patient 
gave written informed consent before be-
ing included in the study.
The study included 30 patients undergoing 
elective lung surgery under general anes-
thesia with employment of OLV (thora-
cotomy with lung resection - pulmectomy, 
bi-lobectomy, lobectomy, segmentectomy) 
or video assisted thoracoscopy (VATS).
Inclusion criteria:
 ■ Patients undergoing lung resection us-
ing thoracotomy (pulmectomy, bilobec-
tomy, lobectomy, segmentectomy) or 
VATS
 ■ Adult patients (18 years and more)
 ■ ASA status 1 or 2
 ■ Preoperative values of SaO2 > 90%
Exclusion criteria:
 ■ Renal failure (creatinine > 114 umol / 
L)
 ■ Hepatic dysfunction (AST > 40U/L, 
ALT > 40U/L)
 ■ Documented coronary or vascular dis-
ease (EF < 50%)
 ■ Pre-existing chronic respiratory disease 
in the non-operated lung
 ■ FVC, FEV1 < 50%, or
 ■ Patients requiring intraoperative FiO2 
> 0.5
Intravenous induction in general anesthe-
sia was performed using midazolam (2-3 
mg), fentanyl (3 μg/kg), propofol (2 mg/
kg) and rocuronium bromide (0.6 mg/kg) 
to facilitate intubation with a  double lu-
men endobronchial tube. Anesthesia was 
maintained with a continuous infusion of 
propofol (6-7 mg/kg/h), with the occasion-
al additional boluses of fentanyl (2 μg/kg) 
to maintain a systolic blood pressure in the 
range of 15 mmHg of post-induction value 
and rocuronium bromide (0.3 mg/kg/h), 
to achieve complete muscular relaxation.
After clinical confirmation of the correct 
position of the double lumen tube in the 
patient placed in  a supine, as well as in the 
lateral decubitus position, volume-con-
trolled mechanical ventilation (VC) was 
implemented using an oxygen-air mixture 
= 50-50% (FiO2= 0.5 for all patients) and 
tidal volume of 6 ml/kg, with respiratory 
rate determined so as to maintain the par-
tial pressure of carbon dioxide in the ar-
terial blood (PaCO2) between 35 and 45 
mmHg (4,5 - 6 kPa). Ventilated lung dur-
ing OLV received PEEP of 5 cm H2O. No 
CPAP was applied to non-ventilated lung 
for treatment of hypoxia during OLV. Also, 
no ligation of the pulmonary artery was 
done by the surgeon for the same reason.
After induction in general anesthesia, in 
all patients an arterial catheter was placed 
in the radial artery contra-lateral to the 
operated hemithorax, in order to extract 
arterial blood samples for acid base status 
(ABS), with arterial blood gas analysis and 
calculation of the value of intrapulmonary 
shunt.
During anesthesia we monitored heart 
rate (HR) via an ECG, invasive mean arte-
rial pressure (MAP), respiratory rate (RR), 
oxygen saturation from pulse oxymetry - 
SAT%, fraction of inspired oxygen - FiO2, 
ABS with arterial blood gas analysis.
Dynamics of measurements - In four 
phases, always with the patient in a lateral 
decubitus position: 1. T0 – during TLV; 2. 
T1 – after commencement of OLV; 3. T2 
- 10 min. after commencement of OLV; 4. 
T3 - 30 min. after commencement of OLV.
Blood samples for arterial blood gas analy-
sis were drawn simultaneously from the 
arterial catheter and analyzed no later than 
10 minutes afterwards, using the gas ana-
lyzer AVL Compact 3 Blood Gas Analyzer 
(AVL LIST GmbH Medizintechnik, Aus-
tria). 
Parameters monitored in the four phases
1. Partial pressure of oxygen in arterial 
blood - PaO2; 
2. Oxygen saturation of arterial blood - 
SaO2; 
3. Value of the intrapulmonary shunt - 
Qs/Qt.
Intrapulmonary shunt - Qs/Qt% can be 
calculated using Fick’s formula for venous 
mixture:
Qs/Qt% = (Cc’O2 - CaO2) / (Cc’O2 - CvO2) 
x 100
Cc’O2 = (Hb x 1.39) x SaO2 (PaO2 x 0.0031)
C (a or v) O2 = (1.39 x Hb x SaO2) (0.0031 
x PO2), 
(PO2 indicates either PaO2 or PvO2)
However, for the purpose of this study we 
have used the mathematically calculated 
value of Qs/Qt% directly from the read-
ings of the printed blood gas analysis re-
sults, obtained using the gas analyzer AVL 
Compact 3 Blood gas. 
This analyzer, based on measured values 
(pH, pCO2, PO2) and input values (patient 
temperature, total hemoglobin, hemo-
globin type, P50 adult, P50fetal, respirato-
ry quotient, FiO2), performs mathematical 
calculations of several parameters (actual 
bicarbonate, base excess, base excess at ac-
tual oxygen saturation, total CO2, standard 
bicarbonate, standard pH, hydrogen ion 
concentration, functional oxygen satura-
tion, oxygen content, alveolar to arterial 
oxygen partial pressure difference, stand-
ardized ionized calcium, PO2 at patient 
temperature, PCO2 at patient temperature, 
pH at patient temperature, intrapulmo-
nary shunt). 
Relative Shunt volume - The value Qs/Qt is 
the fraction of venous blood that remains 
un-oxygenated after traveling from the 
right side of the heart to the left side of the 
heart. This fraction includes the effects of 
true shunts (i.e., anatomic shunts and true 
capillary shunts) along with the effects of a 
ventilation-perfusion mismatch. 
Qs/Qt = (ctO2c – ctO2a) / (ctO2c – ctO2ṽ)
with 
ctO2a – ctO2 ṽ ≈ 5.15 ml/dl
ctO2c ≈ ctO2A
Calculation of ctO2A:
ctO2A = 1.39ctHbSaO2 + 0.00314PaO2  
ml/dl
Calculation of ctO2a:
SO2 =  cO2Hb / (cO2Hb + cHHb) x 100 
(Appendix 12-22, equation 13)
CtO2 = O2ct + 0.00314 x PO2 
(with co-oximetry data)
or
CtO2 = 1.39 x cHb x SO2 + 0.00314 x PO2 
(no co-oximetry data)  
(Appendix 12-23, equation 15)
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Calculation of ctO2 ṽ:
With co-oximetry data:  ctO2a = (ctHba / ctHb 
ṽ) ctO2ṽ + 0.00314 PṽO2  
ml/dl
Without co-oximetry data and with meas-
ured mixed venous PO2-values, the equa-
tions (13,15) are used for the calculation of 
ctO2 ṽ -value.
Without co-oximetry data and without 
measured mixed venous PO2-values, the 
equation (15) is used for the calculation of 
ctO2 ṽ -value
The above described relations are only 
available for a body-temperature of 37 °C. 
If the patient’s temperature is other than 37 
°C, the numerical results are senseless and 
therefore are not printed. (17)
Estimates of Qs/Qt 
Approximation by the clinical shunt equa-
tion to Qs/Qt is provided by estimating the 
normal arterial to venous oxygen content 
difference.
Whichever method is used to estimate the 
intrapulmonary shunt, it should be noted 
that the value of estimating the shunt is in 
its ability to help identify changes in lung 
dysfunction. A change in intrapulmonary 
shunt can indicate an improvement in the 
patient’s condition if the shunt is decreas-
ing. If the shunt is, however, increasing, 
the clinical condition may be deteriorat-
ing. The use of intrapulmonary shunt 
estimates, allows the clinician to more 
routinely analyze changes in the patient’s 
pulmonary status. Without estimating the 
intrapulmonary shunt, the clinician is lim-
ited in understanding how much of a dis-
crepancy exists between how well the lungs 
are presently oxygenating the blood versus 
how well they should be oxygenating the 
blood. This understanding is important 
based on the levels of clinical support be-
ing given, that is increased FiO2, PEEP 
and mechanical ventilation. In addition, 
use of shunt estimates helps the clinician 
avoid simply looking at the PaO2 level. The 
shunt estimates encourage at least simul-
taneous analysis of FiO2 and PaO2. It is 
important to remember that measurement 
of intrapulmonary shunt does not identify 
which condition exists. It only reveals the 
extent of the pulmonary dysfunction in-
duced by the clinical condition. As such, 
the intrapulmonary shunt is not a diag-
nostic tool but is used in the assessment of 
changes in lung function. (18)
The ‘rationale’ behind Qs/Qt calculation
Clinical application of the shunt equation 
is limited by the requirement for a mixed 
venous blood sample. Two methods have 
been used to estimate CvO2 without the 
need for a pulmonary artery catheter. A 
vena caval blood sample can be substituted 
with fair accuracy, but it still requires the 
use of a central line. Alternatively, an es-
timated shunt can be calculated using an 
assumed arterial-venous oxygen content 
difference (C, a v)O2). Although it can vary 
widely with critical illness, this technique 
has been updated and used clinically. 
Seear et al. calculated the intrapulmonary 
shunt using a non-invasive technique and 
compared it to an invasive “gold standard” 
in an animal model of acute lung injury. 
Although the correlation coefficient be-
tween the two measurements was 0.95, 
the scatter of results demonstrated by the 
Bland and Altman plot shows that the non-
invasive prediction can only be viewed as 
an approximation of the true value. Their 
results are comparable with other non-
invasive techniques for estimating Qs/Qt. 
Calculations based on substituting a vena 
caval blood sample generated a correlation 
coefficient of 0.974 which compares well 
with their coefficient of 0.95. There is a 
limit to the approximations that any math-
ematical equation will tolerate. The various 
attempts to estimate Qs/Qt without the 
need for a pulmonary arterial blood sam-
ple are no exception. Small improvements 
in accuracy are possible by substituting 
measured values for some of the assumed 
variables but the final result is still only 
a prediction. The assumptions underly-
ing their mathematical model are based 
on extensive experience with critically ill 
children, but clearly cannot be expected 
to sum up every single patient. However, 
the small improvement in accuracy would 
hardly justify the extra work. The ongoing 
debate concerning the value of pulmonary 
artery catheters, reflects the trend towards 
non-invasive monitoring. A balance has 
to be found between the information de-
rived from invasive catheters and the po-
tential risk of side effects. At a time when 
non-invasive techniques are increasing in 
sophistication, it is probable that the ne-
cessity to derive Q~ - by whatever means 
– will decrease, making it unlikely that iso-
shunt lines will have much clinical value. 
However, a detailed understanding of car-
diopulmonary physiology will always be 
essential. This study has shown that their 
predictive equation provides a realistic 
model that gives a useful tool for teaching 
the physiology of oxygen transport. (19)
Statistical Analysis
Databases were created using specific 
computer programs for this purpose. Their 
processing was performed using standard 
descriptive and analytical bivariant and 
multi-variant methods. Attribute statisti-
cal series were analysed by determining 
the ratio of relations, proportions, rates 
and determining the statistical significance 
among the detected differences. The nu-
merical series were analysed with meas-
ures of central tendency and measures of 
dispersion of data. Statistical significance 
of differences between attributive series 
were tested using the Student t-test. The 
likelihood of association between the fre-
quency distributions of the two attribute 
variables was assessed by x2-test. Statisti-
cal significance of differences was analyzed 
with ANOVA test, which was further con-
firmed by the post hoc HSD (honest sig-
nificant difference) test. CI (confindence 
interval) was set to p<0.05. Results were 
displayed in tables and graphics.
RESULTS
The study results are presented in tables (1-
10) and figures (1-5).
Among patients in the study, 76.66% males 
and 23.3% females were registered. The 
difference between sexes is statistically sig-
nificant for p = 0.003 (table 1). The aver-
age age of patients was 49.96 ± 16.6 years, a 
minimum of 17 and maximum of 74 years 
(table 2). The average weight of patients 
was 75.4 ± 1.0 kg, with minimum of 53.7 
kg and maximum of 105 kg (table 2). Ac-
cording to the American Society of Anes-
thesiologists Classification, ASA, 36.7% 
of patients were ASA 1 and 63.7% ASA 2, 
with a statistically insignificant difference 
of p = 0.144 (table 3).
The average HR (bpm) values show a rise 
during intraoperative monitoring from T0 
to T3 (from 85.5 to 88.5), (table 4, figure 
4). The differences in average HR values 
for different measurements according to 
ANOVA test are statistically insignificant 
for p>0.05. The average values of MAP 
(mmHg) illustrate an increase during in-
traoperative monitoring from T0 to T2, 
and then decrease in T3 (from 86.4 - 94.4 
– 95.2 to 91.5 mmHg). The discrepancy of 
average values of MAP in different meas-
urements, consistent with ANOVA test is 
statistically significant for p=0.019. From 
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the additionally performed post-hoc test 
for MAP (table 6-10), it is obvious that the 
difference is statistically relevant between 
Т0 and Т1 (0.01), as well as Т0 and Т2 
(0,008), (tables 4- 6, figure 5).
The average values of PaO2 (kPa) show a 
fall during the intraoperative monitoring 
(from 23.29 to 15.66 kPa) (table 7, figure 
1). The dissimilarities in these average val-
ues during different measurements, con-
sistent with ANOVA test, are statistically 
significant for p=0,000002. From the addi-
tionally performed post-hoc test for PaO2 
(table 8) it is obvious that the difference is 
statistically relevant between Т0 and Т2 
(p=0.0001); Т0 and Т3 (p=0.0003); Т1 and 
Т2 (p=0.02). 
The average values of SaO2 (%) illustrate a 
decrease during intraoperative monitor-
ing (from 99.1 to 95.3%) (table 7, figure 2). 
The dissimilarities in these average values 
during different measurements, consistent 
with ANOVA test, are statistically relevant 
for p=0.000008. From the additionally per-
formed post-hoc test for SaO2 (table 9), it 
is evident that the difference is statistically 
significant between Т0 and Т2 (p=0.0001); 
Т0 and Т3 (p=0.004); Т1 and Т2 (p=0.003). 
The acquired statistically significant differ-
ences for PaO2 and SaO2 during different 
intraoperative measurements show that 
sometime after initiation of OLV (after 10 
min.) hypoxia develops, with a decrease in 
the values of PaO2 and SaO2. 
The average values of Qs/Qt illustrate 
a dynamic trend during intraoperative 
monitoring. It begins with the value 1% 
in Т0, increases to 8.03% in Т2, and then 
it decreases in Т3 to 3.9% (table 7, figure 
3). The variations in these average values 
for different measurements, in accordance 
with ANOVA test, are statistically rel-
evant for p=0.0007. With the additionally 
performed post-hoc test for Qs/Qt (table 
10), it is evident that the difference is sta-
tistically significant between  Т0 and Т2 
(p=0.0005); as well as Т1 and Т2 (p=0.01). 
The obtained statistically significant  dif-
ferences for  Qs/Qt  during the four meas-
urements demonstrate that some time after 
beginning of OLV (after 10 min.) hypoxia 
develops, with an increase in the value of 
the intrapulmonary shunt. 




                       p value=0,003
Table 2. Distribution of patients by age and weight
Age average ± Stan.Dev.
49,96 16,62
Weight average ± Stan.Dev.
75,36 13,95
Table 3. Distribution by ASA status
ASA number %
ASA 1 11 36,66
ASA 2 19 63,33
                  p value = 0,144
      
Table 4. Average values of MAP and HR during the four measurements 
Parameters average ± St. Dev.
HR T0, bpm 85,56 12,53
HR T1, bpm 85,43 10,98
HR T2, bpm 88,03 12,86
HR T3, bpm 88,53 12,19
MAP T0,mmHg 86,43 11,41
MAP T1,mmHg 94,40 11,82
MAP T2,mmHg 95,23 13,56
MAP T3,mmHg 91,50 10,06
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Mean 86,43 94,4 86,43 95,23 86,43 91,5 94,4 95,23 94,4 91,5 95,23 91,5
Variance 130,25 139,90 130,25 184,11 130,25 101,36 139,90 184,11 139,90 101,36 184,11 101,36
Observations 30 30 30 30 30 30 30 30 30 30 30 30
Pooled Variance 135,07 157,18  115,80 162,009 120,63 142,73
Hypothesized Mean Difference 0 0 0 0 0 0
Df 58 58 58 58 58 58
t Stat -2,65 -2,71 -1,82 -0,25 1,02 1,21
P(T<=t) one-tail 0,005 0,004 0,036 0,40 0,15 0,11
t Critical one-tail 1,67 1,67 1,67 1,67 1,67 1,67
P(T<=t) two-tail 0,01* 0,008* 0,07 0,80 0,31 0,23
t Critical two-tail 2,001  2,001  2,001  2,001  2,001  2,00
Table 6. Post hoc test for MAP, p value from two sample t-test
MAP T0 MAP T1 MAP T2 MAP T3
MAP T0 0,01* 0,008* 0,07
MAP T1 0,80 0,31
MAP T2 0,23
MAP T3
Table 7. Average values of the parameters of intraoperative arterial blood gas status
Parameters average  Stan.Dev.
PaO2 T0 23,29 7,97
PaO2 T1 18,93 7,05
PaO2 T2 13,78 5,84
PaO2 T3 15,66 6,62
SaO2 T0 99,06 0,81
SaO2 T1 97,30 3,48
SaO2 T2 93,52 6,03
SaO2 T3 95,31 4,62
Qs/Qt T0 1 0
Qs/Qt T1 2,79 5,11
Qs/Qt T2 8,03 10,59
Qs/Qt T3 3,94 6,21
Table 8. Post- hoc - Tukey honest significant difference (HSD) test for PaO2
PaO2 T0 T1 T2 T3
T0 0,07 0,0001 0,0003
T1 0,07 0,02 0,26
T2 0,0001 0,02 0,71
T3 0,0003 0,26 0,71
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Table 9. Post- hoc - Tukey honest significant difference (HSD) test for SaO2
SaO2 T0 T1 T2 T3
T0 0,37 0,0001 0,004
T1 0,37 0,003 0,25
T2 0,0001 0,003 0,35
T3 0,004 0,25 0,35
Table 10. Post- hoc - Tukey honest significant difference (HSD) test Qs/Qt
Qs/Qt T0 T1 T2 T3
T0 0,72 0,0005 0,32
T1 0,72 0,01 0,90
T2 0,0005 0,01 0,08
T3 0,32 0,90 0,08
DISCUSSION
OLV creates an obligatory transpulmonary 
shunt through the collapsed lung. Passive 
(gravity and surgical manipulation) and 
active (HPV) mechanisms minimize the 
diversion of blood flow to the collapsed 
lung and prevent the excessive fall of PaO2; 
however, the most significant diversion of 
blood flow to the dependent lung is caused 
by HPV. (20)
Hurford et al. in a study (21) tested the 
hypothesis that intraoperative hypoxemia 
during LV is likely to happened when there 
is a greater preoperative pulmonary blood 
flow in the operated lung. Their study ex-
amined 30 patients who underwent tho-
racic surgical procedures in the lateral 
decubitus position using OLV in whom a 
preoperative ventilation-perfusion scan 
was performed. The percentage of blood 
flow in the operated lung seen on preop-
erative perfusion scan correlated inversely 
with PaO2 after 10 min. of the start of OLV 
(r =-.72). When the percentage of blood 
flow in the operated lung on the preopera-
tive scan was greater than 45%, likelihood 
of hypoxemia (PaO2<75 mm Hg) was 
greater. Because in these patients preop-
erative regional ventilation was equivalent 
to regional perfusion, the percentage of 
preoperative ventilation also correlated in-
versely with PaO2 after 10 min. of the com-
mencement of OLV (r =-.73). Preoperative 
arterial blood gas analysis, pulmonary 
function tests, nor lung volumes did not 
correlate with oxygenation during OLV.
This contradicts the results of Slinger and 
colleagues. (22) In their study they found 
that an equation with three variables [PaO2 
during intraoperative two lung ventilation 
(TLV) in lateral decubitus position, side of 
operation and preoperative value of rela-
tionship forced expiratory volume in 1st 
second/vital capacity (FEV1/VC), can be 
used to predict (p =.73) PaO2 during OLV 
using application of continuous positive 
airway pressure (CPAP) to the unventilat-
ed lung. However, Katz and colleagues (23) 
agree with the findings of Hurford and as-
sociates (21) that routine preoperative gas 
analysis of arterial blood and pulmonary 
function tests do not accurately predict 
which patients are at risk of hypoxemia 
during OLV.
The results from our study confirm that 
preoperative blood gas analysis obtained 
from arterial blood, as well as FVC (forced 
vital capacity) and FEV1 cannot be taken 
as conclusive evidence that a particular pa-
tient will develop a greater or lesser degree 
of hypoxia during OLV.
Previous clinical studies have shown con-
troversial results regarding oxygenation, 
shunt fraction and hemodynamic param-
eters during OLV. (24-27)
Van Keer et al. (24) studied 10 patients 
who underwent thoracotomy. Anesthesia 
was maintained with continuous intrave-
nous infusion of propofol (10 mg/kg/h). 
During TLV and OLV no changes were 
observed in the CO, the shunt fraction and 
PaO2. This could be due to methodologi-
cal differences, since the measurements 
during OLV were started before the open-
ing of the chest. Kellow et al. (25) studied 
patients undergoing thoracotomy and no-
ticed a significant increase in cardiac index 
and shunt fraction during the change from 
TLV to OLV. However, the interpretation 
of the shunt fraction is limited because 
patients were ventilated with 50% nitrous 
oxide in oxygen and PaO2 was not assessed 
for. Steegers and co-workers (26) studied 
14 patients who underwent a lobectomy 
in general anesthesia with continuous iv 
infusion of propofol (6-9 mg/kg/hr). The 
fraction of the shunt and PaO2 did not 
differ in comparison of TLV/OLV. Their 
study did not include any basic data such 
as CO. Changes in these hemodynamic pa-
rameters would cause secondary changes 
in the pulmonary circulation. (25) Spies et 
al. (27) compared TIVA with propofol (10 
mg/kg/hour) versus 1 MAC enflurane in 
patients who underwent thoracotomy. CO 
and intrapulmonary shunt significantly in-
creased when changing from TLV to OLV, 
while PaO2 decreased by definition.
Several studies, including that of Slinger 
and colleagues (28) showed that early hy-
poxemia occurred approximately 5-10 
minutes after commencement of OLV and 
reached a maximum level after 15 min-
utes. This corresponds to the time it takes 
for absorbent gases (oxygen and nitrous 
oxide) to be completely absorbed by the 
closed cavities where blood flow is main-
tained. PaO2 and Qs/Qt usually begin to 
return to the values that existed in TLV 
after about 30 minutes of commencement 
of OLV. This period is necessary to develop 
a compensatory mechanism of HPV that 
will divert blood flow away from the col-
lapsed lung tissue. As a result, the shunt 
fraction will decrease.
Our results confirmed the findings of the 
recently mentioned studies, in that when 
changing from TLV to OLV in a patient 
placed in the lateral decubitus position 
during thoracotomy/thoracoscopy, there 
is a decline in arterial oxygenation and an 
increase in the fraction of intrapulmonal 
shunt. Namely, the average values of PaO2 
showed a decline during intraoperative 
monitoring (from 23.29 +/- 7.97 kPa at 
TLV, to 13.78 +/- 5.84 kPa after 10 min. of 
OLV, and a return to 15. 66 +/- 6.62 kPa af-
ter 30 min. of OLV); average values of SaO2 
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showed a decrease during intraoperative 
monitoring (from 99.06 +/- 0.81% in TLV 
to 93.52 +/- 6.03% after 10 min. of OLV, 
with a return to 95.31 +/- 4.62% after 30 
min. of OLV); and average values of Qs/Qt 
showed dynamic movement throughout 
intraoperative monitoring (starting with 
value <1% in T0, rising to 8.03 +/- 10.59% 
in T2, with a drop in this value to 3.94 +/- 
6.21% in T3).
The hemodynamic measurements show 
that MAP, similar to the intrapulmonary 
shunt, significantly increased when chang-
ing from TLV to OLV (T0 to T1 and T2, 
and then decrease in T3, ie. average values 
- from 86.4 mmHg at TLV to 94.4 mmHg 
at beginning of OLV and 95.2 mmHg af-
ter 10 min of OLV, dropping again to 91.5 
mmHg 30 min after commencement of 
OLV). These changes of invasive mean ar-
terial pressure are similar to the alterations 
of the shunt during the four measurements 
in the study.
Statistically significant differences obtained 
for PaO2, SaO2 and Qs/Qt, showed that af-
ter a certain time from the commencement 
of OLV (10 min.), hypoxia develops with a 
decline in the values of PaO2 and SaO2, as 
well as an increase in the value of the in-
trapulmonary shunt, which is on the other 
hand followed also by a rise of mean arte-
rial pressure. Repeated reduction in Qs/Qt 
in the fourth measurement (T3), suggests 
the development of HPV in this period 
and reduction of the shunt fraction 30 min. 
from the initiation of OLV in the lateral de-
cubitus position during thoracic surgery.
Nonetheless, our study has some limita-
tions. Namely, CO and PvO2 (partial pres-
sure of oxygen in mixed venous blood) 
which are important factors for assessment 
of the impact of HPV on oxygenation, 
were not measured. Instead, we have tried 
to make some analogy between hemody-
namic changes in our patients with the 
alterations of oxygenation status by using 
the values of MAP obtained by invasive ar-
terial pressure measurement.
CONCLUSION
In patients undergoing OLV during gen-
eral anesthesia, the development of hy-
poxia occurs with a decline in PaO2 and 
increase in the value of intrapulmonary 
shunt after a certain period of time follow-
ing commencement of OLV (10 min.). This 
is followed by a return of PaO2 and Qs/Qt 
to values close to normal (30 min. of OLV) 
due to the development of compensatory 
mechanisms (HPV).
ABBREVIATIONS:
1. LDP = lateral decubitus position 
2. OLV = one lung ventilation 
3. TLV = two lung ventilation 
4. PEEP = positive end expiratory pres-
sure
5. CPAP = continuous positive airway 
pressure
6. Va/Qt = ventilation/perfusion ratio
7. Qs/Qt% =  intrapulmonary shunt
8. PO2 = partial pressure of oxygen (a=in 
arterial blood, v=in mixed venous 
blood, A=in the alveoli)
9. PCO2 = partial pressure of carbon di-
oxide (a=in arterial blood, v=in venous 
blood, A=in the alveoli)
10. FRC = functional residual capacity
11. FiO2 = inspired oxygen fraction 
12. PVR = pulmonary vascular resistance 
13. HPV = hypoxic pulmonary vasocon-
striction 
14. TIVA = total intravenous anesthesia 
15. MAC = minimal alveolar concentration 
16. COPD = chronic obstructive pulmo-
nary disease 
17. ASA = „American Society of Anesthe-
siologists“ (classification)
18. SaO2 = oxygen saturation of arterial 
blood 
19. AST = aspartate amino transferase
20. ALT = alanine amino transferase 
21. ЕF = ejection fraction 
22. CO = cardiac output 
23. FEV1 = forced expiratory volume in 1st 
sec. 
24. FVC = forced vital capacity 
25. VC = volume controlled mechanical 
ventilation
26. PC = pressure controlled mechanical 
ventilation 
27. HR = heart rate 
28. ECG = electrocardiography 
29. MAP = mean arterial pressure 
30. RR = respiratory rate 
31. SAT% = oxygen saturation from pulse 
oximetry  
32. Cc'O2 =  oxygen content of pulmonary 
capillary blood 
33. CaO2 =  oxygen content – ml O2/100 
ml arterial blood 
34. CvO2 =  oxygen content – ml O2/100 
ml venous blood
35. Hb = hemoglobin
36. 1.39 = Hifner coefficient (1g Hb binds 
1.39 ml O2 when totally saturated)
37.  0.0031 = coefficient of oxygen dissolu-
tion in plasma 
38. VATS = video assisted thoracoscopic 
surgery
39. ctO2c =  oxygen content at patient tem-
perature in pulmonary capillary blood
40. ctO2a =  oxygen content at patient tem-
perature in arterial blood
41. ctO2ṽ = oxygen content at patient tem-
perature in mixed venous blood
42. ctO2A = oxygen content at patient tem-
perature in alveoli
43. pH = hydrogen ion activity
44. PCO2 = partial pressure of carbon di-
oxide
45. PO2 = partial pressure of oxygen
46. BP = actual barometric pressure
47. ctHb = hemoglobin oxygen capacity at 
PCO2 = 40 mmHg
48. BE = base excess
49. BEecf = base excess of extra cellular 
fluid
50. BEact = base excess at actual oxygen 
saturation
51. BB = buffer base
52. HCO3 = actual bicarbonate
53. cHCO3 = standard bicarbonate at a 
PCO2 = 40 mmHg
54. ctCO2 = PCO2 of 40 mmHg
55. pHst = standard pH value at a PCO2 of 
40 mmHg
56. AaDO2 arterial-alveolar oxygen partial 
pressure difference
57. cH+ = hydrogen ion concentration
58. SO2 = oxygen saturation
59. ctO2 = oxygen content
60. relative shunt volume = measurement 
for the direct mixture venous blood in 
the oxygenated circulatory system
61. P50 value = the oxygen partial pres-
sure at which the hemoglobin is half-
saturated with oxygen (half-saturation 
tension)
62. tHb = total hemoglobin
63. FiO2 = fraction of inspired oxygen 
64. RQ = respiratory quotient
65. ctCO2 = total CO2 in plasma
66. ctO2 = oxygen content
67. cO2Hb = concentration of oxyhemo-
globin in arterial blood
68. cHHb = concentration of deoxyhemo-
globin in arterial blood
69. cO2Hb + cHHb = concentration of total 
hemoglobin capable of binding oxygen
70. cH+=hydrogen ion concentration
71. ctCO2 = total CO2 in plasma
72. cHCO3st = standard Bicarbonate
73. pHt = pH at patient temperature
74. PCO2t = PCO2 at patient temperature
75. PO2t  = PO2 at patient temperature
76. AaDO2t = alveolar-arterial oxygen ten-
sion difference
77. bpm = beats per minute
78. mmHg = millimeters of mercury
79. kPa = kilopascals
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